Oxford, AstraZeneca launch work on Omicron-targeted vaccine -FT
Dec 21 (Reuters) - Oxford University and AstraZeneca Plc have begun work to produce an Omicron-targeted version of their coronavirus vaccine, the Financial Times reported https://www.ft.com/content/e61faf47-d563-4a87-8f0c-dcf7b8b28b43 on Tuesday. ...
Read more